Drugs / CHLORSULFAQUINOXALINE
CHLORSULFAQUINOXALINE
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00008372 | Dec 2000 → Sep 2002 | lung cancer | City of Hope Medical Center | Completed | No outcome recorded |
| Phase 2 | NCT00005864 | Apr 2000 → Feb 2004 | colorectal cancer | Ohio State University Comprehensive Cancer Center | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CHLORSULFAQUINOXALINE | ChEMBL registry synonym — accepted as the source's own label CHEMBL1905073 ↗ |
| Known as | chloroquinoxaline sulfonamide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00005864 ↗ |
| Known as | NSC-339004 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1905073 ↗ |
| Modality | Small molecule | — CHEMBL1905073 ↗ |
| Route | Intravenous | “chloroquinoxaline sulfonamide IV over 1 hour” NCT00005864 ↗ |